Ottawa blocking Canadians’ access to innovative drugs
Health Canada’s revisions to the drug-pricing review board will delay or prevent access to new drugs
Read MoreHealth Canada’s revisions to the drug-pricing review board will delay or prevent access to new drugs
Read MoreConcerns about density are misplaced – Toronto and Vancouver have plenty of room to grow up and grow more affordable
Read MoreIntroducing new regulations and taxes to diminish executive pay will ultimately damage the Canadian economy
Read MoreThe advantage this country once had over the United States has been spun on its head. And that means investment will start heading south in droves
Read MoreGoals imposed by Ottawa rob provinces of the flexibility to adjust policy. And the feds could add conditions over time, using funds as leverage
Read More